Twelve Below — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Caladan Bio develops high-throughput benchtop bioreactor hardware and software for laboratory bioprocessing, enabling faster experimentation and lower costs for biotech R&D teams.
AI & Machine LearningBiotechHardwareNew York, US
Michael Kobida(Founder)inRob Jauquet(Founder)inMichael J. Kobida(Executive Officer, Director)Robert Jauquet(Executive Officer, Director)
Co-investorsCollaborative FundLerer HippeauRitual CapitalWireframe VenturesFactorial Capital
Miami, US
Robert Nance(Executive Officer, Director, Promoter)Madalyn Armijo(Director, Promoter)
BoardChris Downer(Director)inDavid Jegen(Director)inRafi Lurie(Director)
Co-investorsBrewer Lane VenturesCoFound Partners VentureF-Prime CapitalFika VenturesRitholtz Wealth Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.